Early Detection of Erlotinib Treatment Response in NSCLC by 3′-Deoxy-3′-[ 18 F]-Fluoro-L-Thymidine ([ 18 F]FLT) Positron Emission Tomography (PET)

Roland T. Ullrich, Thomas Zander, Bernd Neumaier et al. · 2008

Read Early Detection of Erlotinib Treatment Response in NSCLC by 3′-Deoxy-3′-[ 18 F]-Fluoro-L-Thymidine ([ 18 F]FLT) Positron Emission Tomography (PET) by Roland T. Ullrich, Thomas Zander, Bernd Neumaier et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0003908.txt.

Description

Roland T. Ullrich, Thomas Zander, Bernd Neumaier, and co-authors tested early scans of lung cancer treatment in 2008. Their PLOS ONE article concerns advanced non-small cell lung cancer. A drug called erlotinib blocks a growth receptor that some tumors depend on. Doctors need fast ways to tell whether the drug is working.

The team used PET scans with a tracer called FLT to watch tumors early. Changes in the scan can show tumor growth slowing soon after treatment starts. Early reads let doctors switch failing treatments sooner. The approach may spare patients weeks on a drug that brings no gain.

Catalog record

CREATORRoland T. Ullrich, Thomas Zander, Bernd Neumaier et al.
YEAR2008
COLLECTIONPAPERS
FORMATTXT
FILE SIZE21 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0003908

Browse the full library · About the Tower of Babel